Reviva Pharmaceuticals Holdings, Inc. (RVPH)

CIK 1742927 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Reviva Pharmaceuticals Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0000312069-26-000222
Aug 12, 202610-Q0001437749-26-027358
Aug 12, 20268-K0001437749-26-027356
Aug 3, 2026SCHEDULE 13G/A0001104659-26-089899
Jul 31, 2026SCHEDULE 13G/A0001610520-26-000096
Jul 10, 202625-NSE0001354457-26-000658
May 15, 2026SCHEDULE 13G/A0001649553-26-000058
May 14, 2026SCHEDULE 13G0000312069-26-000174
May 13, 20268-K0001437749-26-016760
May 13, 20268-K0001437749-26-016538
May 13, 202610-Q0001437749-26-016762
May 7, 2026SCHEDULE 13G0001610520-26-000060
Apr 15, 20268-K0001437749-26-012303
Mar 30, 2026S-80001437749-26-010181
Mar 30, 2026SCHEDULE 13G0001104659-26-036874
Mar 30, 20268-K0001437749-26-010140
Mar 30, 202610-K0001437749-26-010126
Mar 25, 2026SCHEDULE 13G0001649553-26-000036
Mar 24, 2026SCHEDULE 13D/A0001493152-26-012362
Mar 20, 202640001437749-26-009260
Mar 20, 202640001437749-26-009258
Mar 19, 20268-K0001437749-26-009063
Mar 19, 2026424B50001437749-26-009062
Mar 18, 2026424B50001437749-26-008843
Mar 5, 20268-K0001437749-26-006991